Gland Pharma (GLAND) — Announcement

📢 Key Event
USFDA inspection concluded with zero Form 483 observations at Visakhapatnam facilities

💡 Investor Takeaway
The zero observation outcome validates the company’s manufacturing compliance and reduces regulatory risk for its oncology portfolio.

Gland Pharma announced the conclusion of a USFDA GMP inspection at its Visakhapatnam sterile oncology and API facilities, which ended with zero Form 483 observations, indicating no regulatory violations found during the August 24–September 1, 2026 inspection. This outcome reflects strong compliance standards and supports uninterrupted market access for critical oncology products. The filing, submitted as a regulatory disclosure under SEBI norms, underscores the company’s adherence to global quality benchmarks. No financial impact or operational changes were disclosed, and no forward guidance was provided. The result is viewed as a positive development for investor confidence in manufacturing reliability.

📄 View Original Announcement (PDF)

📊 Stock Analysis — GLAND ✨ Ask AI About This

About Gland Pharma Ltd (GLAND)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹47,316.21 Cr P/E: 41.9 ROE: 10.9% ROCE: 15.2% Div Yield: 0.70%

View full GLAND stock details →

📡 Get AI alerts when GLAND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GLAND — Free

💡 Ask AI about this filing

"How does this inspection result affect Gland Pharma's US market revenue outlook?" "What is the company's history of USFDA inspection outcomes over the past two years?" "Are there any pending regulatory reviews for other facilities that could impact operations?"

Ask AI Free →

📊 More GLAND filings

See all GLAND filings →

🔥 Also filed on 1 September 2026

FORTIS Fortis Healthcare Ltd Announcement JNPR Juniper Green Energy Ltd Announcement 544083 Shree Marutinandan Tubes Ltd Annual Report SUDARSCHEM Sudarshan Chemical Industries Ltd Announcement CORDSCABLE Cords Cable Industries Ltd Annual Report SUNPHARMA Sun Pharmaceutical Industries Ltd Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GLAND files new disclosures

Track GLAND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GLAND — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd